标题
Soluble NKG2D ligands limit the efficacy of immune checkpoint blockade
作者
关键词
-
出版物
OncoImmunology
Volume 6, Issue 10, Pages e1346766
出版商
Informa UK Limited
发表日期
2017-07-13
DOI
10.1080/2162402x.2017.1346766
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- DNA Damage in Stem Cells
- (2017) Ilio Vitale et al. MOLECULAR CELL
- Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients
- (2017) Cristina Maccalli et al. OncoImmunology
- Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy
- (2017) Jingyu Zhang et al. Science Advances
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
- (2015) W. Deng et al. SCIENCE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Antibody targeting soluble NKG2D ligand sMIC refuels and invigorates the endogenous immune system to fight cancer
- (2015) Jennifer Wu OncoImmunology
- Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors
- (2015) Andrea Acebes-Huerta et al. OncoImmunology
- Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications
- (2015) Aitziber Buqué et al. OncoImmunology
- Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy?
- (2015) Guido Kroemer et al. OncoImmunology
- Immunological markers and clinical outcome of advanced melanoma patients receiving ipilimumab plus fotemustine in the NIBIT-M1 study
- (2015) Cristina Maccalli et al. OncoImmunology
- ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing
- (2015) Maria Raffaella Zocchi et al. OncoImmunology
- NKG2D signaling in cancer immunosurveillance
- (2014) Alejandro López-Soto et al. INTERNATIONAL JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now